BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 15649201)

  • 21. Pyoderma gangrenosum: an Indian perspective.
    Bhat RM; Nandakishore B; Sequeira FF; Sukumar D; Kamath GH; Martis J; Furtado S
    Clin Exp Dermatol; 2011 Apr; 36(3):242-7. PubMed ID: 21070329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pyoderma gangrenosum--positive effect of cyclosporin A therapy ].
    Krauze E; Lis A; Kamińska-Budzińska G; Wygledowska-Kania M; Pierzchała E; Brzezińska-Wcisło L
    Pol Merkur Lekarski; 2002 Oct; 13(76):336-40. PubMed ID: 12557445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ulcerative pyoderma gangrenosum.
    Sander M; Sander M
    CMAJ; 2019 Sep; 191(38):E1058. PubMed ID: 31548193
    [No Abstract]   [Full Text] [Related]  

  • 24. Use of etanercept in treatment of pyoderma gangrenosum in a patient with autoimmune hepatitis.
    Goldenberg G; Jorizzo JL
    J Dermatolog Treat; 2005; 16(5-6):347-9. PubMed ID: 16428159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiation therapy for recalcitrant pyoderma gangrenosum.
    Rumeileh IA; Furlan C; Minatel E; Mascarin M
    G Ital Dermatol Venereol; 2014 Feb; 149(1):145-8. PubMed ID: 24566575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infantile pyoderma gangrenosum.
    McAleer MA; Powell FC; Devaney D; O'Donnell BF
    J Am Acad Dermatol; 2008 Feb; 58(2 Suppl):S23-8. PubMed ID: 18191692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pyoderma gangrenosum following pacemaker insertion.
    Duncan A; Bharati A; Wu J; Currie P; White SI
    Clin Exp Dermatol; 2009 Apr; 34(3):444-5. PubMed ID: 19309385
    [No Abstract]   [Full Text] [Related]  

  • 28. Mycophenolate mofetil and cyclosporin treatment for recalcitrant pyoderma gangrenosum.
    Hohenleutner U; Mohr VD; Michel S; Landthaler M
    Lancet; 1997 Dec; 350(9093):1748. PubMed ID: 9413469
    [No Abstract]   [Full Text] [Related]  

  • 29. Accelerated healing of pyoderma gangrenosum in Behçet patient treated with cyclosporine and split thickness skin graft.
    Kim DW; Lee BI; Park SH
    Ann Plast Surg; 2008 Nov; 61(5):552-4. PubMed ID: 18948785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous cyclophosphamide pulses in the treatment of pyoderma gangrenosum associated with rheumatoid arthritis: report of 2 cases and review of the literature.
    Zonana-Nacach A; Jiménez-Balderas FJ; Martínez-Osuna P; Mintz G
    J Rheumatol; 1994 Jul; 21(7):1352-6. PubMed ID: 7966084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Penile pyoderma gangrenousm treated with cyclosporine: Case report.
    AlTaleb R; Alajlan A
    J Pak Med Assoc; 2018 Jul; 68(7):1148-1150. PubMed ID: 30317330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coexistence of pyoderma gangrenosum and Sweet's syndrome in a patient with ulcerative colitis.
    Castro-Fernández M; Sánchez-Muñoz D; Ruíz-Granados E; Merchante N; Corzo J
    Am J Gastroenterol; 2007 Dec; 102(12):2865-6. PubMed ID: 18042124
    [No Abstract]   [Full Text] [Related]  

  • 33. Disseminated superficial porokeratosis and pyoderma gangrenosum.
    di Meo N; Fluehler C; Perkan V; Trevisan G
    Dermatol Online J; 2010 Oct; 16(10):15. PubMed ID: 21062609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severe recalcitrant pyoderma gangrenosum responding to a combination of mycophenolate mofetil with cyclosporin and complicated by a mononeuritis.
    Gilmour E; Stewart DG
    Br J Dermatol; 2001 Feb; 144(2):397-400. PubMed ID: 11251582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pyoderma gangrenosum affecting the eye, orbit, and adnexa. A review.
    McElnea E; Stephenson K; Fulcher T
    Orbit; 2018 Feb; 37(1):26-31. PubMed ID: 28862478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pyoderma gangrenosum and systemic lupus erythematosus: a report of five cases and review of the literature.
    González-Moreno J; Ruíz-Ruigomez M; Callejas Rubio JL; Ríos Fernández R; Ortego Centeno N
    Lupus; 2015 Feb; 24(2):130-7. PubMed ID: 25199808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peripheral regional aseptic neutrophilic lymphadenopathy associated with pyoderma gangrenosum.
    Al-Niaimi F; Cox NH
    Br J Dermatol; 2009 Nov; 161(5):1206-7. PubMed ID: 19678821
    [No Abstract]   [Full Text] [Related]  

  • 38. Iliopsoas and intraperitoneal abscesses associated with pyoderma gangrenosum.
    Takahashi A; Nakajima H; Sano S
    J Dermatol; 2017 Sep; 44(9):e218-e219. PubMed ID: 28869344
    [No Abstract]   [Full Text] [Related]  

  • 39. Cyclosporin A in the treatment of rheumatoid associated pyoderma gangrenosum.
    Nisar M; Gawkrodger D; Bax D
    Br J Rheumatol; 1995 Feb; 34(2):182. PubMed ID: 7704469
    [No Abstract]   [Full Text] [Related]  

  • 40. [Cyclosporin A therapy in pyoderma gangraenosum].
    Zumdick M; Schuppe HC; Goerz G
    Hautarzt; 1993 May; 44(5):306-8. PubMed ID: 8320117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.